The largest database of trusted experimental protocols

37 protocols using mog35 55

1

EAE Induction and Homotaurine/GABA Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
All experimental protocols were approved by the UCLA Animal Protection Committee and carried out in compliance with the ARRIVE guidelines and all relevant guidelines and regulations were followed for the experiment. Nine weeks old female C57BL/6 or SJL mice were obtained from the Jackson Laboratory and housed in a specific pathogen-free facility with free access to food and water. C57BL/6 mice were immunized subcutaneously with MOG35-55 (200 µg, > 95% purity, GenScript)) in 50% IFA containing Mycobacterium tuberculosis H37R (5 mg/ml, Difco) in multiple sites near the base of their tail on day 1 and injected intraperitoneally with pertussis toxin (200 ng/mouse) on day 0 and 2. Individual SJL mice were immunized with PLP139-151 (100 µg/mouse, > 95% purity, GenScript) using a similar protocol to that described for C57BL/6 mice. The mice were monitored for EAE onset daily: 0, no disease; 1, limp tail; 2, hind limb weakness; 3, complete hind limb paralysis; 4, quadriplegia; and 5, death. Mice that were in between the clear-cut gradations were scored intermediate in increments of 0.5. When the mice developed EAE with a score of 1 at 10–13 days post-immunization, they were randomized to receive plain water or water containing homotaurine (0.25 mg/ml) or GABA (6 mg/ml).
+ Open protocol
+ Expand
2

Induction and Scoring of Experimental Autoimmune Encephalomyelitis

Check if the same lab product or an alternative is used in the 5 most similar protocols
EAE was induced as in prior studies28 (link). Briefly, at 8 weeks of age, mice were anesthetized with isoflurane and were injected subcutaneously at two sites on the back with a total of 200 μg of myelin oligodendrocyte glycoprotein (MOG) peptide (MOG35–55; Genscript, Piscataway, NJ, USA) emulsified in Complete Freund’s Adjuvant (Difco, Detroit, MI, USA) containing 2.5 mg/ml mycobacterium tuberculosis (Difco). Control mice were injected with an equal volume of phosphate buffered saline (PBS) and Complete Freund’s Adjuvant. In addition, each animal received 200 ng pertussis toxin (List Biological, Campbell, CA, USA) in 0.1 ml PBS by i.p. injection at 0 h and 48 h post-immunization. Severity of EAE was scored using a previously published28 (link)29 (link)30 31 (link)32 (link) 5-point scale: no disease = 0; partial tail paralysis = 0.5; tail paralysis or waddling gait = 1.0; partial tail paralysis and waddling gait = 1.5; tail paralysis and waddling gait = 2.0; partial limb paralysis = 2.5; paralysis of one limb = 3.0; paralysis of one limb and partial paralysis of another = 3.5; paralysis of two limbs = 4.0; moribund state = 4.5; death = 5.0.
+ Open protocol
+ Expand
3

Adoptive Transfer of Autoimmune Encephalomyelitis

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57Bl/6 (10-week-old female) mice were purchased from The Jackson Laboratory, immunized subcutaneously with 200 μg myelin oligodendrocyte glycoprotein peptide (MOG35-55; GenScript) mixed 1:1 with supplemented complete Freund’s Adjuvant followed by 200 ng of mouse pertussis toxin (PTX; List Biological Laboratories) i.p. at day 0 and day 2. For adoptive transfer, spleens from active immunized mice were isolated and RBC were lysed. Spleen cells were cultured in presence of MOG35-55 (20 μg/mL) with rmIL-23 (20 ng/mL) for 48 hours. Cells were collected and re-suspended in PBS and 15 million cells were injected intravenous. See supplemental material and methods for detailed description of disease severity scoring. All experiments were performed in accordance with approved Institutional Animal Care and Use Committee (IACUC) protocols of University of Southern California
+ Open protocol
+ Expand
4

Experimental Autoimmune Encephalomyelitis Induction

Check if the same lab product or an alternative is used in the 5 most similar protocols
EAE was induced according to prior studies23 (link),24 (link). Briefly, 8 week old female C57BL/6J mice (N = 18) were anesthetized with isoflurane and were injected subcutaneously at two sites on the back with a total of 200 μg of myelin oligodendrocyte glycoprotein (MOG) peptide (MOG35–55; Genscript, Piscataway, NJ, USA) emulsified in Complete Freund’s Adjuvant (Difco, Detroit, MI, USA) containing 2.5 mg/ml mycobacterium tuberculosis (Difco). Control mice (N = 9) were injected with an equal volume of phosphate buffered saline (PBS) and Complete Freund’s Adjuvant. Each animal also received 200 ng pertussis toxin (List Biological, Campbell, CA, USA) in 0.1 ml PBS by intraperitoneal injection at 0 h and 48 h post-immunization. Severity of EAE was scored using a previously published23 (link)–25 (link) 5-point scale: no disease = 0; partial tail paralysis = 0.5; tail paralysis or waddling gait = 1.0; partial tail paralysis and waddling gait = 1.5; tail paralysis and waddling gait = 2.0; partial limb paralysis = 2.5; paralysis of one limb = 3.0; paralysis of one limb and partial paralysis of another = 3.5; paralysis of two limbs = 4.0; moribund state = 4.5; death = 5.0.
+ Open protocol
+ Expand
5

Induction and Scoring of Experimental Autoimmune Encephalomyelitis (EAE)

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eight-week-old mice were immunized subcutaneously on the back with two injections of 150 μg myelin oligodendrocyte glycoprotein peptide (MOG35–55, GenScript, Piscataway, NJ, USA) emulsified in complete Freund’s adjuvant (CFA; Difco Laboratories, Franklin Lakes, NJ, USA) containing 2.5 mg/mL heat-killed Mycobacterium tuberculosis. Mice were further injected intraperitoneally with 200 ng pertussis toxin (List Biological, Campbell, CA, USA) in 0.1 mL of PBS at 0 and 48 h postimmunization with MOG35–55. Mice were weighed daily to ensure weight loss did not exceed 20% of the starting weight. To document disease induction, EAE clinical manifestations of progressive ascending paralysis were assessed daily using a standard scoring system: no disease = 0; partial tail paralysis = 0.5; tail paralysis or waddling gait = 1.0; partial tail paralysis and waddling gait = 1.5; tail paralysis and waddling gait = 2.0; partial limb paralysis = 2.5; paralysis of one limb = 3.0; paralysis of one limb and partial paralysis of another = 3.5; paralysis of two limbs = 4.0; moribund state = 4.5; death = 5.0 [27 (link)].
+ Open protocol
+ Expand
6

Induction and Analysis of EAE in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Young (3–4 m) and aged (15 m) old C57BL/6J female mice were acquired from Charles River Laboratories. Anesthetised mice were immunised with subcutaneous injections of 150 µg of MOG35-55 (GenScript) emulsified in 200 µl of complete Freud’s adjuvant (CFA) (Incomplete Freund’s Adjuvant containing 2.5 mg/mL Mycobacterium tuberculosis H37Ra, both BD Biosciences). At 0- and 2-days post-immunisation, mice were injected with 200 ng of pertussis toxin intraperitoneally (PHZ1174, Thermofisher). EAE clinical signs and weight were monitored daily from 7 days post-immunisation. Mice were euthanised at 36 days post-immunisation by transcardial perfusion with PBS followed by 4% PFA. Spinal cords were dissected and immersed overnight in 4% PFA at 4 °C. Next, spinal cords were cryoprotected with 30% sucrose (Sigma-Aldrich) in PBS for 72 h and snap-frozen in OCT (Tissue-Tek). Frozen spinal cords were cryosectioned at 12 µm thickness and immunostained as described below.
+ Open protocol
+ Expand
7

Induction of Experimental Autoimmune Encephalomyelitis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Clean-grade (SPF) healthy female C57BL/6 mice (6 weeks old and 18–20 g weight) were purchased from Hunan STA laboratory animal Co. Ltd. Mice were used in the experiment after being fed for one week. The antigen emulsion was placed in an ice box to ensure that the reagent emulsification process was always at low temperature. The emulsion was stirred with an electronic stir bar for 10 minutes in an ice bath. Each 0.2 mL of antigen emulsion contained 400 μL MOG35-55 (GenScript, USA), 0.1 mL PBS, 0.1 mL CFA, and 800 μg Mycobacterium tuberculosis lyophilized powder (Absin, China). After intraperitoneal injection of mice with 1% sodium pentobarbital sodium, the mice in the experimental group received 0.2 ml of PBS solution at 0 and 48 hours after immunization. Normal control mice were given an equal volume of PBS + CFA. Mice were observed and neurologically scored to understand progression daily from the day of immunization.
+ Open protocol
+ Expand
8

Experimental Autoimmune Encephalomyelitis Induction

Check if the same lab product or an alternative is used in the 5 most similar protocols
EAE was induced by immunization with myelin oligodendrocyte glycoprotein peptide 35-55 (MOG35-55, GenScript) in Complete Freund's Adjuvant (CFA, Sigma) and mice were monitored for disease as previously described42 (link).
+ Open protocol
+ Expand
9

Peptides and Recombinant Proteins for Autoimmune Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
MOG aa35-55 (pMOG35-55; M-E-V-G-W-Y-R-S-S-F-S-R-V-V-H-L-Y-RN-G-K); MOG aa 61-85 (pMOG61-85; Q-A-P-E-Y-R-G-R-T-E-L-L-K-D-A-I-G-E-G-K-V-TL-R-I); and Hen's Egg Lysozyme (HEL) aa 46-61 (pHEL46-61; N-T-D-G-S-T-D-Y-G-I-LQ-I-N-S-R). Initially, peptides were synthesized by Sigma-Genosys (The Woodlands, TX). More recently, MOG35-55 and MOG61-85 were synthesized by Genscript (Piscataway, NJ). Proteolipid Protein (PLP) aa 180-199 (pPLP280-199; W-T-T-C-Q-S-IA-F-P-S-K-T-S-A-S-I-G-S-L) was synthesized by Genscript (Piscataway, NJ). The purity of all peptides was confirmed by HPLC. Human rMOG (hrMOG) consisting of the 120-amino acid extracellular domain of MOG, was isolated from the culture supernatant of High-5 insect cells infected with a recombinant baculovirus expressing the hrMOG protein, as previously described (Devaux et al., 1997 (link)).
+ Open protocol
+ Expand
10

Experimental Autoimmune Encephalomyelitis Induction

Check if the same lab product or an alternative is used in the 5 most similar protocols
For active EAE induction, age- and sex-matched mice were immunized s.c. with MOG35-55 (Genscript, purity >98%) peptide (300 μg) emulsified in CFA containing 4 mg/ml heat-killed MTB (Cat#7001,Chondrex). 200 ng Pertussis toxin (Cat#181239A1, List Biological Laboratories) dissolved in PBS was administered i.p. on days 0 and 2. Mice were examined daily and scored for disease severity using the standard scale: 0, no clinical signs; 1, limp tail; 2, paraparesis (weakness, incomplete paralysis of one or two hind limbs); 3, paraplegia (complete paralysis of two hind limbs); 4, paraplegia with forelimb weakness or paralysis; 5, moribund or death. After the onset of EAE, food and water were provided on the cage floor. Mononuclear cells were prepared from the CNS (brain and spinal cord) of EAE-induced mice as described and analyzed by flow cytometry.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!